Cooper Total Long Term Liabilities 2010-2024 | COO

Cooper total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Cooper total long term liabilities for the quarter ending July 31, 2024 were $3.213B, a 1.2% increase year-over-year.
  • Cooper total long term liabilities for 2023 were $3.139B, a 3.34% increase from 2022.
  • Cooper total long term liabilities for 2022 were $3.037B, a 57.21% increase from 2021.
  • Cooper total long term liabilities for 2021 were $1.932B, a 1.25% increase from 2020.
Cooper Annual Total Long Term Liabilities
(Millions of US $)
2023 $3,139
2022 $3,037
2021 $1,932
2020 $1,908
2019 $1,535
2018 $2,269
2017 $1,287
2016 $1,240
2015 $1,217
2014 $1,428
2013 $393
2012 $466
2011 $420
2010 $659
2009 $836
Cooper Quarterly Total Long Term Liabilities
(Millions of US $)
2024-07-31 $3,213
2024-04-30 $3,291
2024-01-31 $3,372
2023-10-31 $3,139
2023-07-31 $3,175
2023-04-30 $3,212
2023-01-31 $3,310
2022-10-31 $3,037
2022-07-31 $3,093
2022-04-30 $3,116
2022-01-31 $3,072
2021-10-31 $1,932
2021-07-31 $1,762
2021-04-30 $1,858
2021-01-31 $1,971
2020-10-31 $1,908
2020-07-31 $1,859
2020-04-30 $1,857
2020-01-31 $1,749
2019-10-31 $1,535
2019-07-31 $1,668
2019-04-30 $1,720
2019-01-31 $1,935
2018-10-31 $2,269
2018-07-31 $2,569
2018-04-30 $2,766
2018-01-31 $2,697
2017-10-31 $1,287
2017-07-31 $1,318
2017-04-30 $1,467
2017-01-31 $1,319
2016-10-31 $1,240
2016-07-31 $1,535
2016-04-30 $1,534
2016-01-31 $1,447
2015-10-31 $1,217
2015-07-31 $1,199
2015-04-30 $1,241
2015-01-31 $1,436
2014-10-31 $1,428
2014-07-31 $393
2014-04-30 $395
2014-01-31 $393
2013-10-31 $393
2013-07-31 $320
2013-04-30 $401
2013-01-31 $494
2012-10-31 $466
2012-07-31 $555
2012-04-30 $362
2012-01-31 $456
2011-10-31 $420
2011-07-31 $490
2011-04-30 $609
2011-01-31 $664
2010-10-31 $659
2010-07-31 $685
2010-04-30 $758
2010-01-31 $791
2009-10-31 $836
2009-07-31 $855
2009-04-30 $906
2009-01-31 $918
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.623B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74